Distinct Differences in Lipoprotein Particle Number Evaluation between GP-HPLC and NMR: Analysis in Dyslipidemic Patients Administered a Selective PPAR α Modulator, Pemafibrate.

CONCLUSIONS: GP-HPLC evaluates the lipoprotein PNs more accurately than NMR and can be used for assessing the effects of lipid-lowering drugs on lipoprotein subclasses. PMID: 33536398 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/33536398?dopt=Abstract

Source: Journal of Atherosclerosis and Thrombosis - February 6, 2021 Category: Cardiology Tags: J Atheroscler Thromb Source Type: research